Thursday, 29 October 2026
13:00-13:30hrs
Jen Jen Yeh
USA
Molecular Subtypes of Pancreas Cancer and Implications for Management
Biography
Dr. Yeh has an active surgical oncology practice focused on patients with melanoma, endocrine and pancreatic cancers. Her research interests have been focused on integrating clinical, computational and biological approaches to tackle the complexities of pancreatic cancer. Her work has included identification and understanding tumor-intrinsic molecular subtypes of pancreatic cancer that are prognostic and may predict treatment response. Dr. Yeh was co-founder of a start-up focused on the advancement of iontophoretic delivery of oncology drugs for challenging tumors such as pancreatic cancer. She currently leads the UNC Selective Targeting of Pancreatic Cancer P50 SPORE and a U01 in the Pancreatic Cancer Stroma Reprogramming Consortium (PSRC). Her long-term goal of her research is to identify promising approaches for pancreatic cancer and accelerating their translation to the clinic.
Jen Jen Yeh, MD
Oliver Smithies Investigator
Professor of Surgery and Pharmacology
Vice Chair of Research, Department of Surgery
Director, UNC Lineberger Pancreatic Cancer Center of Excellence
co-Associate Director of Education, co-Clinical Research Program Leader, UNC Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Tin Tin Mar
Myanmar
Managing Bile Duct Disorders in a Resource Constraint Environment
Biography
Prof. Tin Tin Mar is practicing as a surgeon in the private sector like: Asia Royal Hospital, Shwe Gondine Hospital and Aryu Hospital after retirement.
Her interest is both malignant and benign HBPS diseases. She collaborated on academic activities with Seoul National University Hospitals and Korea Transplant Society for liver transplant, outreach activity of IHBPA & A-PHBPA, ASEAN LHC, ASEAN CCA. Fellowship program was initiated at University of Medicine (1) Yangon and “Work together, Learn together and Share together” is motto for her department.
Prof. Tin Tin Mar
Prof/ Head (Retired)
HBPS Department
Yangon Speciality Hospital
Yangon
Myanmar
Dieter Broering
Saudi Arabia
Current and Next Generations in Robotic Liver Transplantation
Biography
Prof. Dr. Dieter Broering is the Executive Director of the Organ Transplant Centre of Excellence at King Faisal Specialist Hospital & Research Centre (KFSH&RC) and a Professor of Surgery at Alfaisal University, Riyadh, Saudi Arabia, a role he has held since 2010. He graduated in Medicine from the University of Dusseldorf in 1992, became Board Certified in Surgery in Hamburg in 1997, earned his PhD in Surgery (Habilitation) at the University of Hamburg in 2004, and completed a second PhD in Clinical Hepatology at Semmelweis University, Budapest, in 2006. He was elected Fellow of the American College of Surgeons in 2018 and Honorary Fellow of the European Surgical Association in 2024.
Prof. Broering served as Chairman of the Surgery Department at King Faisal Specialist Hospital & Research Centre (KFSH&RC) from October 2010 to August 2020.
He has published over 443 articles in peer-reviewed journals, achieving a remarkable total Impact Factor of more than 1412.5 and his work has been recognized nationally and internationally. He has delivered numerous scientific presentations and invited lectures at prestigious conferences and institutions worldwide.
A world-renowned multi-organ transplant surgeon and an international expert in Living Donor Liver Transplantation, Prof. Broering has pioneered numerous transplantation programs for living and deceased liver donations for both pediatric and adult patients. His work has included innovations in split liver transplantation, minimally invasive and robotic donor hepatectomy and nephrectomy. Under his leadership, the Organ Transplant Center of Excellence at KFSH&RC has achieved significant milestones, positioning Saudi Arabia among the world’s leading centers in organ transplantation, especially excelling in Robotic Transplant Surgery.
The Center is now leading internationally in Robotic Donor Hepatectomy, having performed to date 1,468 robotic donor hepatectomies (1,450 full robotic with 2 converted cases and 6 donors robotic-assisted) since November 2018 (the largest series in the world); and 526 robotic nephrectomies since January 2020. It is the only Center now wherein 100% of all liver donors are benefiting from minimal invasive robotic transplant surgery procedures. (As of 31 August 2025).
Prof. Dr. med. Dieter Broering, MD, PhD, FEBS, FACS
Executive Director, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital & Research Centre,
Professor of Surgery, Alfaisal University, Riyadh, Saudi Arabia
Friday, 30 October 2026
13:00-13:30hrs
Guido Torzilli
Italy
Surgical Strategies for R0 Resection and Combined Vascular Resection
Biography
Dr Guido Torzilli is full Professor of Surgery at the Department of Biomedical Science of the Humanitas University, and Director of the Department of Surgery and of the Division of Hepatobiliary Surgery at the Humanitas Research Hospital in Milan, Italy.
He graduated in Medicine cum laude and honor and was trained and board certificated cum laude in General Surgery at the University of Milan (Italy). Dr Torzilli was granted of the Japanese Fellowship for Promotion of Cancer Research. In Japan Dr Torzilli carried out his research at the University of Tokyo, where he obtained the PhD degree in Hepatobiliary surgery, and then served as Assistant Professor of Surgery in the Department of Hepatobiliopancreatic Surgery and Transplantation of the University of Tokyo chaired by his Mentor and Master of Surgery Professor Masatoshi Makuuchi.
Dr Torzilli has carried out several successful clinical studies focused on hepatobiliary diagnostic imaging, interventional oncology, and surgery. As one of the leading surgeons in the use of intraoperative ultrasound, pioneering new intraoperative imaging modalities (i.e. contrast enhanced intraoperative ultrasound), and original surgical interventions in hepatobiliary surgery as the Anatomical resections by IOUS- guided compression, the Systematic Extended Right Posterior Sectionectomy, the Mini-mesohepatectomy, the Liver Tunnel, the Transversal Hepatectomies, the Sliced Liver Hepatectomy ecc…). Worth to be mentioned are the concept of R1 vascular surgery, and the clusters approach, cutting-edge concepts in hepatobiliary surgical oncology opening to the advanced parenchyma sparing liver resection.
Dr Torzilli is a founding member of the Eastern and Western Liver Tumor Association, the founder and first President of the Italian Association of Hepatobiliary Surgery (AICEP), fellows of the American College of Surgeons, fellows and chair of the Membership Committee of the European Surgical Association and Board members of several National and International Scientific Societies. Dr Torzilli has been awarded for his scientific contributions by the Italian Society of Surgery, appointed of the Layton Rikkers Master Clinician Award 2023 by the SSAT, and appointed as honorary member of the American Surgical Association, the Association Française de Chirurgie, the Colegio Brasileiro de Cirurgia Digestiva, the Compagnons Hepatobiliaire, and the Portuguese, Bulgarian, Chilean, Hungarian, Romanian, and Serbian Society of Surgery. Dr Torzilli has been invited as Visiting Professor for lecturing in several prestigious Institutions and Universities in North America, Europe and Asia.
Doctor Torzilli co-authored more than 400 publications, several books’ chapters and 2 books, delivering around 800 lectures at national and international meetings. He is member of the Editorial Board of several international peer-reviewed Journals devoted to surgery, hepatology, and oncology.
In his carrier Dr Torzilli has always paid great attention to transmit his surgical approach with courses and regularly hosting observer from all over the world.
Finally, Doctor Torzilli has Mentored many colleagues now directors and chairmen and has founded the Residency Program in General Surgery at Humanitas University, which has been ranked along his 7 years chairmanship as 1st Italian Residency program in 2020 and 2022, and 2nd in 2019 and 2021
Rajesh Gupta
India
Acute Necrotizing Pancreatitis
Biography
Prof. Rajesh Gupta did his postgraduation and further 3 year subspecialisation in GI Surgery from Postgraduate Institute of Medical Education and Research, located at Chandigarh (North India), an Institute of national importance. He has been holding this faculty position in the same Institute since 1999. Prof. Gupta started the department of GI Surgery in his Institute in August 2020 and has been heading this department since then. It is now renamed as Department of GI Surgery, HPB and Liver transplantation.
Prof. Gupta has published more than 300 papers in peer reviewed journals with his group and a large part of his research and publications have focussed on acute pancreatitis involving surgical and endoscopic aspects of management of IPN along with ductal adenocarcinoma of pancreas. He has published 13 book chapters and has been Associate editor of one book. They have published on use of Streptokinase as necrolytic agent in infected pancreatic necrosis to help improve the efficacy of pigtail catheter drainage which is now routinely employed in the Department. He delivered 23 international and 136 national talks. His group have presented 82 scientific papers at international and 61 presentations at national forums.
Prof. Gupta has been guest editor for Surgery Open on Acute Pancreatitis, and is currently Senior Associate Editor of Journal of Postgraduate Medicine, Education and Research (JPMER), and also, Associate Editor of Journal of Digestive Endoscopy and has been a Member of the Editorial Board of Surgery Open Science till recently.
Professor Rajesh Gupta
Professor and Head, Department of GI Surgery, HPB and Liver Transplantation
Postgraduate Institute of Medical Education and Research, Chandigarh, India 160012
Saturday, 31 October 2026
13:00-13:30hrs
Xueli Bai
China
Laparoscopic and Robotic HPB Surgery including Transplant (LDLT)
Biography
Xueli Bai, the “Yangtze River Scholar” Distinguished Professor appointed by the Ministry of Education of China, Qiushi Distinguished Professor at Zhejiang University, and recipient of the State Council Special Allowance, has long focused on hepatobiliary-pancreatic surgery and liver transplantation. Her work emphasizes clinical innovation, mechanistic investigation, and robotic minimally invasive techniques for hepatobiliary and pancreatic tumors. As Principal Investigator, she leads a portfolio of national grants includes Key Projects of the National Natural Science Foundation, the Ministry of Education’s Pioneering Program for Disciplinary Breakthroughs, and National Key R&D Program sub-projects. Driven by the goal of translating discoveries into longer and better lives for patients, she has designed and is steering three parallel clinical trial platforms—CISLD (liver cancer), CISPD (pancreatic cancer), and CAPT (solid tumors). She has published more than 250 SCI papers in leading journals such as Nature, Cancer Cell, and Gut. She has served as deputy editor or deputy translator for five medical monographs and has authored 15 national expert consensuses. For her scientific contributions, she has received five provincial/ministerial-level science and technology awards, including the First Prize of the Zhejiang Provincial Natural Science Award and the First Prize of the Zhejiang Provincial Science and Technology Progress Award.
Mariano Gimenez
Argentina
Computer Assisted Surgery in HPB: Role of Artificial Intelligence and Automation
Biography
Dr. Mariano Giménez, MD, PhD, FSIR, graduated from the University of Buenos Aires (UBA), Argentina in 1984 and earned his Doctor of Medicine degree in 1996, receiving the Faculty Prize for the best thesis of the year. In 1993, he pioneered the specialty of Image-Guided Percutaneous Surgery, a field in which he has since trained physicians worldwide. He is Full Professor of Surgery at UBA, Director of its Chair of General and Minimally Invasive Surgery, and has served as Professor of Percutaneous Surgery at the University of Strasbourg, France (2018–2020).
Dr. Giménez is President of the DAICIM Foundation, former Scientific Director of Percutaneous Surgery at IHU Strasbourg (2018–2025), and currently Director of Image-Guided Surgery at IRCAD, Strasbourg. He has authored over 150 peer-reviewed articles, 13 books, 112 chapters, and delivered more than 1,200 lectures in 42 countries. His innovations include a patented surgical navigation system and leadership in developing a robotic platform for liver interventions, awarded the 2023 Force Foundation Prize.
He is Honorary Member of numerous societies, FSIR (USA), Co-Chair of the ILLS Innovation Committee, and President of the AHPBA (2024–2025). Recognized with the KONEX Award (Argentina, 2023) and Gazi Zibari Award (USA, 2023), he was named Doctor Honoris Causa by the University of the Republic (Uruguay) in 2025.
Nancy Kwan Man
Hong Kong
Investigating Methods to Reduce Cancer Recurrence After Resection and Transplantation for Liver Cancer
Biography
Prof. Nancy Kwan Man is well-recognized internationally for the advancements of liver transplantation research. Her innovative development and successful application of integrated clinical, translational and basic research for liver graft injury and cancer recurrence after transplantation, has resulted in major advances and impact on transplant oncology and immunology in the world. Her research achievements have been dully recognized by her numerous prestigious international awards, invited plenary and state-of-art lectures in leading congresses of transplantation, leaderships of international academic societies, journal editorship and leading role of international consensus/guideline of transplant oncology and immunology.
She has published more than 250 papers in international journals including Transplantation, Liver Transplantation, Annals of Surgery, JAMA Surgery, Clinical Cancer Research, Cancer Research, Small, Theranostics, Journal of Hepatology, Hepatology, Gastroenterology, Nature Medicine & New England Journal of Medicine etc with H index 76 (total citation > 18000). She is one of the Top 1% Scholars at University of Hong Kong according to ISI’s Essential Science Indicators during 2013 -2019 and she is also in the top 2% Scientists Worldwide on Stanford List 2020-25.
Nancy K Man
Chair Professor of Transplant Oncology and Immunology
Director, Clinical and Translational Research
Director of the Laboratory for Liver Transplantation and Liver Cancer
Director of the Laboratory for Organ Transplantation and Tissue Repair
Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong
President of International Liver Transplantation Society (ILTS) (2018-19)
President of Hong Kong Scientist Association (HKSA) (from 2018)
President of Hong Kong Society of Immunology (HKSI) (from 2023)
Transplantation: Deputy Editor (Since 2015)
Annals of Surgery: Editorial Board (Since 2018)
Founder of OncoImmuNostics Ltd
